Targovax ASA赞助的临床试验
总计3955个结果
-
Targovax Oy完全的PD1 阻断后进展的晚期或不可切除的黑色素瘤美国, 挪威
-
Targovax ASA终止
-
Targovax OyTheradex未知确定 ONCOS-102 联合化疗的安全性、耐受性和疗效西班牙, 法国
-
Oslo University HospitalTargovax ASA招聘中
-
University of Kansas Medical CenterTargovax ASA尚未招聘
-
Georgetown UniversityBristol-Myers Squibb; Targovax ASA; Janssen, LP招聘中
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLC; Targovax ASA完全的
-
Nykode Therapeutics ASAVaccibody AS完全的
-
Nykode Therapeutics ASATheradex; Vaccibody AS完全的
-
Nykode Therapeutics ASAGenentech, Inc.; Vaccibody AS主动,不招人
-
Nykode Therapeutics ASANektar Therapeutics; Vaccibody AS完全的
-
BerGenBio ASA主动,不招人
-
BerGenBio ASA招聘中
-
Nykode Therapeutics ASARoche Pharma AG; Vaccibody AS完全的
-
Biotec Pharmacon ASA终止
-
Asan Medical CenterKorea Otsuka International Asia Arab完全的
-
Haukeland University HospitalBerGenBio ASA主动,不招人
-
Serodus ASAThe Research Council of Norway; Smerud Medical Research International AS完全的
-
Ultimovacs ASAOslo University Hospital主动,不招人
-
University of BergenBergen Medical Research Foundation; Skretting ASA; Leroy Seafood Group ASA完全的
-
University of BergenBergen Medical Research Foundation; Skretting ASA; Leroy Seafood Group ASA完全的
-
BerGenBio ASAMerck Sharp & Dohme LLC完全的
-
BerGenBio ASAMerck Sharp & Dohme LLC终止
-
Aristotle University Of ThessalonikiNattopharma ASA尚未招聘死亡 | 腹膜透析 | 晚期肾脏疾病 | 动脉硬化 | 心血管疾病发病率 | 维生素 K 缺乏症